TGFB1 and cancer: First, cancer is prevented by obstructing upstream signaling pathways, such as ligand neutralizing antibodies, dummy receptors, or inhibitors that obstruct TGF-β, NF-κB, EGFR, cMET, WNT, and Notch signaling [146, 147].